Clinical Trials Logo

Pregnancy Related clinical trials

View clinical trials related to Pregnancy Related.

Filter by:

NCT ID: NCT05355012 Recruiting - Smoking Cessation Clinical Trials

Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.

5A-QUIT-N
Start date: October 3, 2022
Phase: N/A
Study type: Interventional

The investigators are conducting a pragmatic cluster randomized trial in stepped-wedge of which objectives are to evaluate the effectiveness and the conditions of effectiveness of an organizational strategy for smoking cessation - 5A-QUIT-N - among pregnant women in New Aquitaine (NA), by using and optimizing existing resources

NCT ID: NCT05352256 Recruiting - Pregnancy Related Clinical Trials

Pregistry International Pregnancy Exposure Registry (PIPER)

PIPER
Start date: October 1, 2022
Phase:
Study type: Observational [Patient Registry]

The aims of the Pregistry International Pregnancy Exposure Registry (PIPER) are to provide early signals of risk after prenatal exposure to medical products and to define boundaries of safety for medical products. The goal is to assist prescribers and study participants in weighing the potential risks of prenatal treatments on the wellbeing of mother and the unborn offspring. Specifically, the PIPER will estimate the risk of obstetric outcomes (spontaneous abortion, antenatal bleeding, gestational diabetes, gestational hypertension, intrauterine growth restriction, postpartum hemorrhage, fetal distress, uterine rupture, placenta previa, chorioamnionitis, Caesarean delivery, COVID-19), neonatal outcomes (major congenital malformations, low birth weight, neonatal death, neonatal encephalopathy, neonatal infections, neonatal acute kidney injury, preterm birth, respiratory distress in the newborn, small for gestational age, stillbirth, COVID-19), and infant outcomes (developmental milestones [motor, cognitive, language, social-emotional, and mental health skills], height, weight, failure to thrive, medical conditions during the first 12 months of life, COVID-19) among pregnant women.

NCT ID: NCT05341960 Recruiting - Pregnancy Related Clinical Trials

Nourishing Beginnings: Addressing Food Insecurity During Pregnancy

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This is a pilot project designed to test the feasibility of implementing a community health worker (CHW)-led intervention to improve nutritious food access and consumption among pregnant people and to evaluate the effectiveness of this approach. The project will be conducted in partnership with the Greater Cleveland Food Bank and the Better Health Partnership Community Health Worker HUB

NCT ID: NCT05341921 Recruiting - Blood Pressure Clinical Trials

Deep Breathing Techniques (Pranayama) in Pregnancy

Start date: August 2, 2022
Phase: N/A
Study type: Interventional

Slow deep breathing actives the vagal nerve and leads to a natural reduction in physiological parameters such as blood pressure, heart rate and digestion. The effects of these techniques have not been assessed in pregnancy. The primary objective is to assess the effects of various yogic deep breathing techniques on blood pressure during pregnancy. The breathing exercises will include Alternate nostril breathing, Bhramari breathing, and Sheetali breathing. A secondary objective will be to assess the effects of these breathing exercises on other physiological parameters including heart rate, heart rate variability, body temperature, cardiac output, vascular resistance and respiratory rate.

NCT ID: NCT05309928 Recruiting - Pregnancy Related Clinical Trials

Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy

Start date: August 29, 2023
Phase: Phase 1
Study type: Interventional

The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.

NCT ID: NCT05300646 Recruiting - Pregnancy Related Clinical Trials

Mindfulness-Based Stress Reduction for Psycho-socially Vulnerable Pregnant Women.

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to address the need for a wider array of evidence-based and non-pharmacological options to improve mental health in a psycho-socially highly vulnerable group of pregnant women. In more detail, the primary outcome is to estimate the effect of prenatal Mindfulness-Based Stress Reduction (MBSR) as an add-on to usual care on mental well-being when compared to usual care alone. Second, to estimate the effect of prenatal MBSR on perceived stress and symptoms of depression and anxiety, and third to explore the effect on maternal bonding and childbirth, e.g. gestational age and experience of childbirth. Finally, to examine the mediating effect of mindfulness and self-compassion on the primary outcome.

NCT ID: NCT05278793 Recruiting - Pregnancy Related Clinical Trials

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.

FER-IDIP
Start date: January 7, 2022
Phase: Phase 4
Study type: Interventional

In this study intermittent dosage of iron supplementation three times a week will be compared to daily dosage in anaemic pregnant women due to iron deficiency.

NCT ID: NCT05256615 Recruiting - Diabetes Clinical Trials

Exercise Timing and Gestational Diabetes

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to understand if the timing of exercise around food intake can help improve blood sugar management in pregnant individuals with diabetes.

NCT ID: NCT05250479 Recruiting - Pregnancy Related Clinical Trials

Effect of Mindfulness Education in Primiparous Pregnant Women

Start date: December 20, 2021
Phase: N/A
Study type: Interventional

While adaptation is generally achieved to the psychological changes that develop during pregnancy, some women may experience psychological changes such as contradiction, uncertainty, introversion, passive personality, addiction, fear, and anxiety in different periods of pregnancy. During this period, the fear of childbirth may also be experienced in pregnant women. Fear of childbirth or tokophobia is a phobic condition in which a woman avoids giving birth despite desperately wanting a baby. While fear of childbirth can have a negative impact on women's psychological health during pregnancy and birth experience, it is associated with negative obstetric outcomes and postpartum mental health problems. It is possible that the fear of childbirth reduces the mother's attachment to the fetus. Fear increases avoidant attachment and anxiety, which may be associated with lower commitment scores. There is a strong relationship between fear of childbirth and negative birth outcomes. Both affect the psychological well-being of the mother, adjustment to motherhood, and the quality of the mother's relationship with the baby. Knowing the fear of childbirth is important as it is associated with various health problems such as certain physiological and obstetric disorders and they can increase the possibility of emergency cesarean section. Mindfulness-based interventions combine elements of established cognitive behavioral therapy and psychoeducational content to support a self-effective approach to reduce stress-related symptoms and improve mental and physical well-being. Mindfulness-based practices that involve focusing on the present moment and accepting life without judgment are one of the effective ways to prepare for childbirth, help women feel more empowered and aware of their motherhood processes, and give mothers the opportunity to share knowledge and emotions. Mindfulness-based birth education intervention appears to be applicable for women and is associated with improvements in women's sense of control and confidence in giving birth.

NCT ID: NCT05245734 Recruiting - Pregnancy Related Clinical Trials

Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women

Start date: February 8, 2022
Phase: Phase 4
Study type: Interventional

Rhesus conflict between mother and fetus is due to the different antigenic composition of erythrocytes. During the first pregnancy, sensitization of the mother to fetal erythrocytes rhesus D (RhD) antigens is formed. During the next pregnancy, fetal red blood cells are attacked by the mother's antibodies, and fetal/newborn hemolytic disease develops. The drug Rhesoglobin blocks the interaction of the fetal erythrocytes RhD antigen and the immune system of the mother and prevents the development of Rhesus sensitization.